Artemisinin: A Panacea Eligible for Unrestrictive Use?

Yuan, Dong-Sheng; Chen, Yan-Ping; Tan, Li-Li; Huang, Shui-Qing; Li, Chang-Qing; Wang, Qi; Zeng, Qing-Ping

Yuan, Dong-Sheng; Chen, Yan-Ping; Tan, Li-Li; Huang, Shui-Qing; Li, Chang-Qing; Wang, Qi; Zeng, Qing-Ping.

Afiliação

Yuan DS; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen YP; Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Tan LL; Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Huang SQ; Basic Medical Science College, Guangzhou University of Chinese Medicine, Guangzhou, China.
Li CQ; Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang Q; Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zeng QP; Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.

Front Pharmacol ; 8: 737, 2017.

Article em En | MEDLINE | ID: mdl-29089893

Palavras-chave

artemisinin; malarial resistance; multi-target; restrictive use; wide-spectrum

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google